Algorithm identifies respiratory illness by the sound of a child’s cough

Combining AI with advances in acoustic engineering, Australian researchers have developed an algorithm that can help diagnose common pediatric respiratory conditions such as asthma, croup and pneumonia.

Lead author Paul Porter, MD, of Curtin University and colleagues used recorded sounds of 585 children aged one month to 12 years old coughing in a number of ordinary clinical environments.

Comparing the performance of their algorithm against consensus clinical diagnoses made by a panel of pediatricians, the researchers found their tool correctly diagnosed asthma 97% of the time and correctly ruled it out with 91% accuracy.

The accuracy of the automated technique was lower for five other conditions but never fell below 81% for either sensitivity or specificity.

“[T]his technology has a role as a high-level diagnostic aid in the assessment of common childhood respiratory disorders,” the authors concluded in their study report, which was published online June 6 in Respiratory Research.

In their discussion, Porter and team add that their system could prove valuable as a diagnostic aid in places lacking clinical expertise, including in emergency settings where pediatric patients are being triaged for possibly urgent treatment.

They further note that their algorithm could be used with smartphone apps as the sound-acquisition mechanism.

“Advantages of using these devices include they meet acoustic requirements (bandwidth, noise levels and transduction-sensitivity) needed for respiratory sound recording; are ubiquitous devices even in the developing world; possess substantial computing power allowing for analyses with no requirement for connectivity; enable non-contact assessments ideal for infection control and for use in children or non-compliant subjects; and are usable in realistic clinical settings where background noise is a factor,” the authors write. “This allows for an all-in-one data acquisition, analysis and decision-making device.”

The study is available in full for free.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup